Literature DB >> 410061

Noradrenaline, depressive illness, and the action of amitriptyline.

K Ghose, A Coppen.   

Abstract

The tyramine-dose/pressor response test was carried out on a series of patients suffering from primary depressive illness before and during treatment with amitriptyline. The severity of their depression was assessed during the study of the Hamilton Rating Scale (HRS). The decreased tyramine sensitivity induced by the drug, which is related to the inhibition of NA reuptake, correlated significantly with the plasma concentration of nortriptyline. However, contrary to the expectation of the noradrenaline hypothesis of depression, the decreased tyramine sensitivity, i.e., the degree of NA-reuptake blockade, did not show any correlation with clinical improvement following 6 weeks' treatment with amitriptyline.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410061     DOI: 10.1007/bf00426542

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  CLINICAL TRIAL OF THE TREATMENT OF DEPRESSIVE ILLNESS. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS CLINICAL PSYCHIATRY COMMITTEE.

Authors:  M THIERY
Journal:  Br Med J       Date:  1965-04-03

2.  INHIBITION OF NORADRENALINE UPTAKE BY DRUGS.

Authors:  L L IVERSEN
Journal:  J Pharm Pharmacol       Date:  1965-01       Impact factor: 3.765

3.  Effects of imipramine on the peripheral autonomic system.

Authors:  M OSBORNE; E B SIGG
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-12-31

4.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

5.  Recent studies on the mode of action of antidepressive drugs.

Authors:  A Carlsson
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

6.  Brain biogenic amine depletion and mood.

Authors:  J Mendels; A Frazer
Journal:  Arch Gen Psychiatry       Date:  1974-04

Review 7.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

8.  Amitriptyline plasma levels and therapeutic response.

Authors:  V E Ziegler; B T Co; J R Taylor; P J Clayton; J T Biggs
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

9.  "Serotonin depression"--a biochemical subgroup within the affective disorders?

Authors:  M Asberg; P Thorén; L Träskman; L Bertilsson; V Ringberger
Journal:  Science       Date:  1976-02-06       Impact factor: 47.728

10.  Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patients.

Authors:  K Ghose; R Gupta; A Coppen; J Lund
Journal:  Eur J Pharmacol       Date:  1977-03-07       Impact factor: 4.432

View more
  11 in total

1.  Peripheral alpha-adrenoreceptor and central dopamine receptor activity in depressive patients.

Authors:  A Coppen; K Ghose
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

Review 2.  Biochemical assessment of antidepressive drugs.

Authors:  K Ghose
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

3.  Assessment of Peripheral adrenergic activity and its interactions with drugs in man.

Authors:  K Ghose
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

4.  Presynaptic alpha-adrenoceptor blocking properties among tri- and tetra-cyclic antidepressant drugs.

Authors:  B Harper; I E Hughes
Journal:  Br J Pharmacol       Date:  1979-12       Impact factor: 8.739

5.  The effect of amitriptyline on presynaptic receptors in the dog saphenous vein [proceedings].

Authors:  M G Collis; J T Shepherd
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

6.  Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness.

Authors:  A Coppen; V A Rama Rao; C R Ruthven; B L Goodwin; M Sandler
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

7.  Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.

Authors:  A Coppen; V A Rama Rao; C Swade; K Wood
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

8.  Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man.

Authors:  A Coppen; K Ghose; C Swade; K Wood
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

9.  The effect of amitriptyline on presynaptic mechanisms in noradrenergic nerves.

Authors:  I E Hughes
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

10.  Decreased tyramine sensitivity after discontinuation of amitriptyline therapy. An index of pharmacodynamic half-life.

Authors:  K Ghose
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.